These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7533086)

  • 21. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
    Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
    J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice.
    Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ
    Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts.
    Choy JC; Kerjner A; Wong BW; McManus BM; Granville DJ
    Am J Pathol; 2004 Jul; 165(1):127-33. PubMed ID: 15215168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of effector mechanisms in murine cardiac allograft rejection.
    Alexander DZ; Pearson TC; Hendrix R; Ritchie SC; Larsen CP
    Transpl Immunol; 1996 Mar; 4(1):46-8. PubMed ID: 8762009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet rejection in perforin-deficient mice: the role of perforin and Fas.
    Ahmed KR; Guo TB; Gaal KK
    Transplantation; 1997 Apr; 63(7):951-7. PubMed ID: 9112346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection.
    Selvaggi G; Ricordi C; Podack ER; Inverardi L
    Transplantation; 1996 Dec; 62(12):1912-5. PubMed ID: 8990386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of cyclosporine treatment on the expression of genes encoding granzyme A and perforin in the infiltrate of mouse heart transplants.
    Mueller C; Shao Y; Altermatt HJ; Hess MW; Shelby J
    Transplantation; 1993 Jan; 55(1):139-45. PubMed ID: 8420038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles.
    Sleater M; Diamond AS; Gill RG
    Am J Transplant; 2007 Aug; 7(8):1927-33. PubMed ID: 17617855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin.
    Grazia TJ; Plenter RJ; Weber SM; Lepper HM; Victorino F; Zamora MR; Pietra BA; Gill RG
    Transplantation; 2010 Jan; 89(1):33-9. PubMed ID: 20061916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8 lymphocytes are sufficient for the development of chronic rejection.
    Schnickel GT; Whiting D; Hsieh GR; Yun JJ; Fischbein MP; Fishbein MC; Yao W; Shfizadeh A; Ardehali A
    Transplantation; 2004 Dec; 78(11):1634-9. PubMed ID: 15591952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic pathways in the skin allograft rejection by CD4+ T cells.
    Ito A; Minagawa M; Tomiyama K; Ito M; Kawai K
    Transplantation; 1999 Jul; 68(1):97-100. PubMed ID: 10428275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granzymes and perforin in solid organ transplant rejection.
    Choy JC
    Cell Death Differ; 2010 Apr; 17(4):567-76. PubMed ID: 19876069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.
    Tao R; Wang L; Han R; Wang T; Ye Q; Honjo T; Murphy TL; Murphy KM; Hancock WW
    J Immunol; 2005 Nov; 175(9):5774-82. PubMed ID: 16237069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-alpha genes in rejecting skin allografts.
    Borson ND; Strausbauch MA; Kennedy RB; Oda RP; Landers JP; Wettstein PJ
    Transplantation; 1999 Mar; 67(5):672-80. PubMed ID: 10096521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting edge: perforin down-regulates CD4 and CD8 T cell-mediated immune responses to a transplanted organ.
    Bose A; Inoue Y; Kokko KE; Lakkis FG
    J Immunol; 2003 Feb; 170(4):1611-4. PubMed ID: 12574320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perforin-dependent cell death in skin allograft rejection of the terrestrial slug Incilaria fruhstorferi.
    Furuta E; Seo N; Yamaguchi K
    Zoolog Sci; 2006 Dec; 23(12):1093-100. PubMed ID: 17261923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of rejection of nonvascularized grafts: the role of perforin and Fas.
    Selvaggi G; Ricordi C; Podack E; Inverardi L
    Transplant Proc; 1997 Jun; 29(4):2075-6. PubMed ID: 9193534
    [No Abstract]   [Full Text] [Related]  

  • 40. Contribution of Fas ligand to cardiac allograft rejection.
    Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
    Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.